From August 17, 2023 to March 31, 2024, the company has repurchased 3,040,219 shares, representing 0.63% for CNY 203.98 million. With this, the company has completed the repurchase of 3,040,219 shares, representing 0.63% for CNY 203.98 million under the buyback announced on August 17, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
57.17 CNY | -1.72% | -2.61% | -14.58% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.58% | 3.78B | |
+0.82% | 93.19B | |
0.00% | 39.62B | |
-10.35% | 33.78B | |
+65.27% | 26.82B | |
-16.15% | 15.35B | |
-6.98% | 13.13B | |
-11.77% | 11.6B | |
-49.19% | 10.26B | |
+3.37% | 9.43B |
- Stock Market
- Equities
- 688363 Stock
- News Bloomage BioTechnology Corporation Limited
- Tranche Update on Bloomage BioTechnology Corporation Limited's Equity Buyback Plan announced on August 17, 2023.